Mechanism and Function Of MBNL Mediated mRNA Localization in Neuronal Development and Neurologic Disease
Project Number5R01NS114253-05
Contact PI/Project LeaderBASSELL, GARY J Other PIs
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
The development and maintenance of neurons and synaptic connections are highly complex processes, in part
due to the massive cytoplasmic volume and complex branching morphology of axons and dendrites. As one
mechanism, it is well appreciated that RNA localization and local translation are required to precisely regulate
protein homeostasis at synapses. Indeed, loss of FMRP in Fragile X Syndrome, or other impairments to RNA
localization and local translation at synapses, likely contribute to brain disorders. To better understand RNA
localization and local translation in neurons, we must elucidate the RNA cis-elements, RBP trans-factors, and
cytoskeletal motors mediating these processes. Although ongoing efforts have demonstrated how RNA binding
proteins (RBPs) can regulate local translation at post-synaptic sites, there still exists a major gap in our
understanding of how RBPs transport RNAs to regulate synaptic function. Fortunately, recent observations
provide clues about fruitful lines of investigation. For example, multiple studies report that distally localized
RNAs are enriched for cis-elements targeted by Muscleblind-like (MBNL) proteins. Although these
observations suggest that MBNL may be a major player in localizing RNAs to the pre- and post-synapse, we
still lack a mechanistic understanding for how MBNL proteins may achieve this task, or what functions depend
on MBNL-mediated RNA localization. This line of research has important implications for the neurological
disease myotonic dystrophy (dystrophia myotonica, DM), in which MBNLs are depleted by toxic CUG repeats.
Therefore, an emerging hypothesis is that RNA localization functions of MBNL are important for proper
synapse function, and that mis-localized RNAs might account for some neurological features of DM patients,
particularly early in disease. Here, using MBNL depletion and DM-associated models, we propose to identify
specific functions for the localization of MBNL targets. Aim 1 will elucidate mechanisms of MBNL-mediated
mRNA localization in neurons. We will define the RNA targets that are localized by MBNL in the pre- and post-synapse. We will characterize dynamic properties of motile MBNL RNA granules in live neurons and identify
cytoskeletal motors and adaptors associated with these granules. Using genomics, live cell imaging, and
biochemical approaches, we will establish mechanisms of how MBNL-interacting RNAs are transported. Aim 2
will define functions conferred by MBNL-dependent RNA localization using models of synapse development
and function, and models of myotonic dystrophy. By depleting cytoplasmic MBNL and other proteins required
for MBNL-dependent RNA localization, we will assess cellular functions dependent on this process. We will
identify specific neuronal functions, such as synaptic vesicle release, that depend on proper localization of
mRNAs by MBNL proteins. The impact of this research is to better understand how RNA localization and local
translation confers important synaptic functions and how they may go awry in DM. As few RNA binding
proteins have been linked to motors, this may evolve into a unifying model for mRNA transport to synapses.
Public Health Relevance Statement
The proposed basic research is focused on better understanding how RNAs are localized and translated in
neurons. Perturbations to these processes occur in many neurological diseases, but we do not have a good
understanding of how RNA localization occurs. This research has implications for many neurological diseases.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
01-February-2020
Project End Date
31-January-2026
Budget Start Date
01-February-2024
Budget End Date
31-January-2026
Project Funding Information for 2024
Total Funding
$390,180
Direct Costs
$287,311
Indirect Costs
$102,869
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$390,180
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS114253-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS114253-05
Patents
No Patents information available for 5R01NS114253-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS114253-05
Clinical Studies
No Clinical Studies information available for 5R01NS114253-05
News and More
Related News Releases
No news release information available for 5R01NS114253-05
History
No Historical information available for 5R01NS114253-05
Similar Projects
No Similar Projects information available for 5R01NS114253-05